Oncoclinicas do Brasil Servicos Medicos SA
BOVESPA:ONCO3
Oncoclinicas do Brasil Servicos Medicos SA
BOVESPA:ONCO3
Price:
1.39
BRL
7.75%
Market Closed
Market Cap:
R$1.6B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Oncoclinicas do Brasil Servicos Medicos SA
BOVESPA:ONCO3
|
BR |
|
I
|
International Jet Engine Supply
NASDAQ:FLYE
|
US |
|
Lennar Corp
NYSE:LEN
|
US |
|
D
|
DevPort AB
STO:DEVP B
|
SE |
|
K
|
Khoon Group Ltd
HKEX:924
|
SG |
|
A
|
ADTechnology Co Ltd
KOSDAQ:200710
|
KR |
|
Pharos Energy PLC
LSE:PHAR
|
UK |
|
DCD Media PLC
LSE:DCD
|
UK |
|
O
|
Oriental Precision & Engineering Co Ltd
KOSDAQ:014940
|
KR |
|
Lombard Medical Inc
OTC:EVARF
|
UK |
|
Pharmaust Ltd
ASX:PAA
|
AU |
|
Adcock Ingram Holdings Ltd
OTC:AIHLF
|
ZA |
|
C
|
China Financial International Investments Ltd
HKEX:721
|
HK |
|
S
|
SecondXight Analytica Inc
TSE:5028
|
JP |
|
Deutsche Post AG
XETRA:DHL
|
DE |
Multiples-Based Value
The
Multiples-Based Value for
Oncoclinicas do Brasil Servicos Medicos SA (ONCO3)
under the Base Case is
hidden
BRL.
Compared with the current market price of 1.39 BRL, the stock appears
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
ONCO3 Multiples-Based Value
LOCKED
Multiples Across Competitors
ONCO3 Competitors Multiples
Oncoclinicas do Brasil Servicos Medicos SA Competitors
Oncoclinicas do Brasil Servicos Medicos SA Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| BR |
|
Oncoclinicas do Brasil Servicos Medicos SA
BOVESPA:ONCO3
|
1.6B BRL | 0.3 | -0.4 | 2.2 | 3.8 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
97.6B USD | 0.2 | 55.2 | 14.1 | 14.1 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
66.9B EUR | 0.3 | 12.9 | 7.6 | 9.7 | |
| US |
|
Cigna Corp
NYSE:CI
|
72.8B USD | 0.3 | 12.2 | 0 | 0 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
24.9B EUR | 1.1 | 19.7 | 9.8 | 14.6 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
22.6B EUR | 1.1 | 23.1 | 8.9 | 16.5 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
21.9B USD | 1.6 | 25 | 12 | 17.4 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
21.1B USD | 1.9 | 21.3 | 11.6 | 15.6 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
10.9B EUR | 0.6 | 11.1 | 5.3 | 9.9 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
11.2B USD | 11.4 | -26.9 | -29.4 | -26.8 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10.2B USD | 0.7 | 13.6 | 7.1 | 9.6 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
